Akums is India’s largest Contract Development and Manufacturing Organization (CDMO), holding a leading position in the domestic market. In FY23, Akums captured a 9.3% market share by value in the Indian domestic CDMO market, with an 8.8% share by volume in the Indian Pharmaceutical Market (IPM). By FY24, its market share by value increased to 10.0%, with a significant 30.2% share by value within the domestic CDMO market. Akums operates 15 state-of-the-art facilities producing a wide range of modern dosage forms across multiple therapeutic segments.

State-of-the-Art Manufacturing Facilities

Our 15 manufacturing units are strategically located and equipped with cutting-edge technology, supporting a wide range of products across multiple therapeutic categories. Each facility is designed for optimal productivity, safety, and compliance, making Akums a pioneer in Contract Development and Manufacturing (CDMO). Our manufacturing plants are certified by leading global health authorities.

Our production units are categorized into dedicated sections for pharmaceuticals, nutraceuticals, herbal, and cosmetics, ensuring specialized handling and production according to the highest regulatory requirements.

Pharmaceuticals
Pharmaceuticals
Nutraceuticals
Nutraceuticals
Herbal
Ayurveda
Cosmetics
Derma | Cosmetics

Manufacturing Facilities to Trust upon

Varied Production

Varied production lines for consistent quality assurance and efficiency.

Environmental Controls

Based on the dosage forms and product requirements, various environmental controls are in place.

Specialized Facilities

Specialized facilities are in place for sterile production, carbapenems, and female hormonal medicine manufacturing.

R&D Centers

Dedicated 4 R&D centers to ensure fastest and seamless technology transfer from development to production.

Large-Scale Manufacturing Capacity

Our vast production capacity enables Akums to handle both small-scale niche projects and large-scale global supply demands. With an annual production capacity of 20 billion units across all dosage forms, we ensure timely delivery and consistency in every batch.

Oral solids icon

47.78

Oral solids

Sterile icon

744.20

Sterile

Liquids icon

417.60

Liquids

External icon

158.40

Topicals

Versatile Dosage Form Capabilities

At Akums, we understand that different therapeutic categories and patient needs demand diverse dosage forms. Our facilities are equipped to handle a vast range of dosage forms, tailored to specific market needs and regulatory environments.

Tablets and Capsules

Immediate and controlled release tablets, multi-layered tablets, chewable tablets, sugar and film-coated tablets, in-lay tablets hard and soft gelatin capsules.

Liquid Orals

Syrups, suspensions, emulsions, solutions, drops, and tinctures, with advanced packaging in HDPE and PET bottles.

Injectables

Ampoules, vials, pre-filled syringes, lyophilized products, and infusions

Topical Formulations

Creams, ointments, gels, lotions, and sprays for dermatological and cosmetic applications.

Comparison
Effervescent Tablets

High-quality effervescent formulations for nutraceuticals and pharmaceuticals, ensuring fast absorption and ease of consumption.

Herbal & Ayurvedic Products

GMP-certified production of ayurvedic tablets, oils, pastes, and powders.

Soft Gel Capsules

Encapsulation of oils, vitamins, and herbal extracts in soft gels, with customized packaging options.

Gummies and Chewables

With the rising demand for vegan, plant-based, and sugar-free alternatives, Akums leads in producing vegan-friendly gummies that meet market trends.

Connect with us to explore cutting-edge solutions and innovation
Contact Us

Our Growth Partners

Meeting the Challenges of Modern Pharmaceutical Manufacturing

Pharmaceutical companies are navigating complex global and domestic landscapes, facing challenges such regulatory compliance across international markets, and increasing demand for new products and formulations. As a trusted CDMO partner, we address these pain points by offering -

Effectiveness and Efficiency

Our approach combines robust quality assurance with streamlined manufacturing processes to enhance both effectiveness and efficiency. This results in reduced production time ensuring customer remain competitive.

Advanced Technology and Expertise

Our investment in cutting-edge technology and a skilled workforce ensures we stay ahead of market trends, offering advanced drug delivery systems, specialized dosage forms, and expertise in formulation development.

Global Reach and Market Expansion

With a strong presence in India and growing global footprints, we support clients in expanding into new markets by navigating the complex regulatory environments, allowing faster and more efficient product launches.

Business Model

CRAMS - Akums Business Model

Contract Research & Manufacturing Services (CRAMS)

Technology Transfer - Akums Business Model

Technology Transfer

Loan License - Akums Business Model

Loan
License

Contract Development - Akums Business Model

Contract Development

N.D.D.S - Akums Business Model

Novel Drug Delivery systems (N.D.D.S)

Technical collaboration & Joint venture - Akums Business Model

Technical Collaboration & Joint Venture

Our Global Presence

In addition to our core CDMO business, we actively engage in marketing our own branded formulations across global markets, and have established an international presence through our subsidiary Unosource. Our international presence extends across 60 countries, and our key clients include Allegens (Vietnam), Ambica International (Philippines), Caferma SAC (Peru), JDS (Myanmar), Master Pharma (Cambodia), Olainfarm (Latvia), Pharma Apex (Myanmar), Planet Pharmaceutical (Tanzania), and Unisel (Kenya), among others.

Comprehensive Quality Assurance and Compliance

Quality is at the core of everything we do. Our Quality Management System (QMS) ensures compliance with international standards from raw material procurement to finished product release. Every product batch undergoes extensive testing including:

In-process quality checks

Stability studies

Dissolution and disintegration testing

Heavy metal and impurity profiling

Our Regulatory Affairs team ensures all products meet global market requirements, facilitating registration, documentation, and audits for seamless international trade.

Open Video

Akums' Commitment to Sickle Cell Disease

Akums has embarked on a transformative journey in the development of a pioneering hydroxyurea treatment, marking a significant stride in the battle against sickle cell disease.

Recognizing the urgent need for innovative therapies, Akums has dedicated extensive resources and expertise to develop a groundbreaking hydroxyurea treatment. This initiative not only addresses the symptomatic relief associated with SCD but also aligns with government efforts to enhance healthcare accessibility and outcomes.

Akums stands at the forefront of transformative healthcare solutions, driven by a vision to improve quality of life and foster healthier futures for individuals impacted by SCD. Ms. Arushi Jain will delve into the journey behind this innovative solution, highlighting the collaborative spirit and scientific rigor that define Akums' approach to healthcare innovation.

API Manufacturing and
Research & Development Facilities

Manufacturing facilities with advanced capabilities, complemented by dedicated R&D laboratories for continuous innovation.

Dera Bassi

This unit is dedicated to the production of beta lactams and is equipped with six production blocks. With an annual capacity of 557.00 MT. This unit enables us to carry out complex multistep synthesis processes, meeting the high demand for beta lactam APIs.

Lalru

This unit is designed for the synthesis of a wide range of APIs spanning various therapy areas. This unit comprises three production blocks and has an annual production capacity of 180.00 MT. At this unit, we produce APIs across a broad spectrum of therapeutic categories.

Barwala

This unit is a specialized small-volume, high-potency API manufacturing unit with an annual production capacity of 0.38 MT. This unit features a kilo lab scale pilot plant for experimental and development purposes and is dedicated to handling high-potency APIs with a high degree of expertise.

Dedicated Research and Development (R&D) Capabilities

Akums has one of the most advanced R&D infrastructures, with teams of experts in formulation development, analytical research, and process optimization. Our R&D division focuses on:

  • New chemical entities (NCE)
  • Modified drug delivery systems
  • Novel dosage forms such as fast-dissolving tablets, sustained-release formulations, and multi-layer tablets
  • Technology transfers for seamless transition from development to production

We work in close collaboration with our clients to innovate and optimize formulations that provide better therapeutic outcomes while adhering to cost efficiency and market needs.

Partner with Akums for Industry-Leading Manufacturing Solutions

From high-volume pharmaceutical production to bespoke formulation development, Akums stands at the forefront of the CDMO industry. Our comprehensive solutions, combined with an unwavering commitment to quality, make us the trusted partner for pharmaceutical companies around the globe.

Connect with us

    Build or Enhance your current supply with Akums